BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $480,000 | -90.1% | 3,174 | -90.4% | 0.00% | -100.0% |
| Q2 2022 | $4,838,000 | +36.7% | 33,204 | +11.2% | 0.00% | +50.0% |
| Q1 2022 | $3,539,000 | -3.3% | 29,849 | +12.5% | 0.00% | 0.0% |
| Q4 2021 | $3,658,000 | +469.8% | 26,544 | +474.7% | 0.00% | – |
| Q3 2021 | $642,000 | +75.9% | 4,619 | +22.7% | 0.00% | – |
| Q2 2021 | $365,000 | +54.0% | 3,763 | +8.5% | 0.00% | – |
| Q1 2021 | $237,000 | +2.6% | 3,469 | +28.8% | 0.00% | – |
| Q4 2020 | $231,000 | -10.5% | 2,693 | -23.8% | 0.00% | – |
| Q2 2020 | $258,000 | +29.0% | 3,535 | -8.8% | 0.00% | – |
| Q1 2019 | $200,000 | +316.7% | 3,877 | +216.2% | 0.00% | – |
| Q2 2018 | $48,000 | +71.4% | 1,226 | +12.9% | 0.00% | – |
| Q1 2018 | $28,000 | +100.0% | 1,086 | +103.4% | 0.00% | – |
| Q4 2017 | $14,000 | -65.9% | 534 | -51.1% | 0.00% | – |
| Q3 2017 | $41,000 | +64.0% | 1,093 | +10.5% | 0.00% | – |
| Q2 2017 | $25,000 | – | 989 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |